Efinaconazole in the treatment of onychomycosis
Shari R Lipner, Richard K Scher Department of Dermatology, Weill Cornell Medical College, New York, NY, USA Abstract: Efinaconazole 10% topical solution is a new triazole recently approved for the treatment of onychomycosis. It inhibits fungal lanosterol 14α-demethylase in the ergosterol...
Main Authors: | Lipner SR, Scher RK |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-06-01
|
Series: | Infection and Drug Resistance |
Online Access: | http://www.dovepress.com/efinaconazole-in-the-treatment-of-onychomycosis-peer-reviewed-article-IDR |
Similar Items
-
Patient considerations in the management of toe onychomycosis – role of efinaconazole
by: LaSenna CE, et al.
Published: (2015-06-01) -
Preparation and in vivo evaluation of a highly skin- and nail-permeable efinaconazole topical formulation for enhanced treatment of onychomycosis
by: Byung Chul Lee, et al.
Published: (2019-01-01) -
Effect of Penetration Enhancers on Toenail Delivery of Efinaconazole from Hydroalcoholic Preparations
by: Jun Soo Park, et al.
Published: (2021-03-01) -
Nitric Oxide-Releasing Nanoparticles Are Similar to Efinaconazole in Their Capacity to Eradicate Trichophyton rubrum Biofilms
by: Caroline Barcelos Costa-Orlandi, et al.
Published: (2021-07-01) -
Propolis for the treatment of onychomycosis
by: Flavia Franco Veiga, et al.
Published: (2018-01-01)